From: Data-driven decision-making for precision diagnosis of digestive diseases
First author, year | Disease | n | Data source and specific task | ML method | Diagnostic performance | Refs. |
---|---|---|---|---|---|---|
Jiménez, 2013 | CRC | 26 | Metabolic profiles of tumor and adjacent tissues by NMR spectroscopy; classification based on discriminant metabolites | OPLS–DA | AUC: 0.910 | [134] |
Yuan, 2021 | ESCC | 525 | Serum lipidomics data; classification based on a panel of 12 lipid biomarkers, age and gender | SVM/PCA | AUC: 0.818–0.966 | [135] |
Takis, 2018 | Diffuse abdominal pain | 64 | Serum metabolomics data by NMR spectroscopy; classification by metabolomics fingerprint | OPLS–DA/PCA | Accuracy > 90% | [136] |
Wang, 2023 | ESCC | 1104 | Serum metabolomics data by LC–MS; classification based on digital images of metabolome profiles | CNN | AUC: 0.950 | [137] |
Yang, 2022 | CRC | 99 | LC–MS-based plasma lipidomics data; classification based on 14 lipids | PLS/RF/SVM/KNN | Accuracy: 72.6–100% | [138] |
Huang, 2021 | GC | 400 | Untargeted metabolomics data of plasma; classification based on 6 metabolites with clinical indicators | LR/RF | AUC: 0.830 | [139] |
Yu, 2023 | GC | 301 | Serum metabolomics data by MS; classification based on 12 differential metabolites | PCA/SVM/RF/LASSO | AUC: 0.893 | [140] |
Matsumoto, 2023 | GC | 101 | Hydrophilic metabolites quantified by LC–TOFMS; classification based on 3 metabolites | SVM | AUC: 0.885–0.915 | [141] |
Pan, 2022 | GC | 280 | Target bile acid metabolomics data of serum; classification based on 6 bile acids | RF/LASSO/OPLS–DA | AUC: 0.940–1.000 | [142] |
Zhao, 2022 | ESCC | 239 | Multi-platform metabolomics data of serum; classification based on 5 metabolites | RF/LASSO/PCA | AUC: 0.873 (95% CI, 0.825–0.925) | [143] |